🔥 biotech 핫 테마 분석

[LFCR] Lifecore reaffirms 2026 guidance, outlines fill/finish demand doubling in 2027 and +200% growth in 2028

[RPRX] Royalty Pharma targets $3.4B-$3.5B 2026 portfolio receipts as it raises guidance again

S-Class [LLY] Eli Lilly in Charts: Mounjaro and Zepbound continue to fuel blockbuster growth in Q2

S-Class [LLY] Eli Lilly Non-GAAP EPS of $8.38 beats by $1.80, revenue of $23B beats by $2.31B

S-Class [LLY] Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge

Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.

S-Class [SNDX] Syndax sees Revuforj U.S. peak net revenue in excess of $2B as Q4 axatilimab readouts approach

[TWST] Twist Bioscience prices $300M stock offering at $96 per share